Join Growin Stock Community!

暐世4197.TW Overview

TW StockBiotech. & Medical
(No presentation for 4197)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

暐世（4197）Overall Performance

暐世（4197）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

暐世（4197） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

暐世（4197）Key Information

暐世（4197）Profile

Visgeneer Inc. provides health solutions in the fields of medical device, cosmetics and skin care, bacterial fermentation, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay mask; physical blocker, chemical blocker, and comprehensive sun protection; face wash, wash cream, cleaning cleansing mousse, cleaning cleansing gel, shampoo, and body wash; hand cream, knee cream, foot mask, hand mask, and glucosamine cream; anti-acne cream, female private cleaning lotion, skin care, skin capsules, and hair capsules; and customized skin care products. In addition, the company offers eBmonitor Blood Monitoring System, CoreSence Skincare, BOWIL Skincare, and ZeaSight EU Patent Zeaxanthin, as well as contract manufacturing services. Visgeneer Inc. was founded in 2005 and is based in Hsinchu City, Taiwan.

暐世（4197）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.69
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.94
PB Ratio
1.48
Price-to-FCF
5.35
METRIC
VALUE
vs. INDUSTRY
Gross Margin
46.63%
Net Margin
-6.76%
Revenue Growth (YoY)
-4.80%
Profit Growth (YoY)
6.62%
3-Year Revenue Growth
20.22%
3-Year Profit Growth
44.09%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.69
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.94
PB Ratio
1.48
Price-to-FCF
5.35
Gross Margin
46.63%
Net Margin
-6.76%
Revenue Growth (YoY)
-4.80%
Profit Growth (YoY)
6.62%
3-Year Revenue Growth
20.22%
3-Year Profit Growth
44.09%
default symbol

4197

暐世

9.59D

-1.98%

(-0.02)

  • When is 4197's latest earnings report released?

    The most recent financial report for 暐世 (4197) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4197's short-term business performance and financial health. For the latest updates on 4197's earnings releases, visit this page regularly.

  • How much cash does 4197 have?

    At the end of the period, 暐世 (4197) held Total Cash and Cash Equivalents of 75.42M, accounting for 0.22 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4197 go with three margins increasing?

    In the latest report, 暐世 (4197) achieved the “three margins increasing” benchmark, with a gross margin of 48.84%%, operating margin of 7.28%%, and net margin of 2.55%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4197's profit trajectory and future growth potential.